The Foundation Fighting Blindness Hosts 16th Annual Love of Sight Dinner to Support Ground-Breaking Research for Restoring Vision
Dinner will fund sight-saving research for devastating retinal conditions including age-related macular degeneration and retinitis pigmentosa; Spark Therapeutics CEO Jeffrey D. Marrazzo and Former Secretary Tommy G. Thompson to be honored
COLUMBIA, MD – May 31, 2018 – The Foundation Fighting Blindness (FFB) will host its annual Love of Sight dinner on Tuesday, June 5, 2018 at The Ritz-Carlton, in Washington, D.C. – cocktails 6:00 p.m., dinner 7:00 p.m.
FFB is the world’s leading private funder of research aimed at preventing, treating and curing the entire spectrum of retinal degenerative diseases. Love of Sight, now in its 16th year, has raised more than $6 million to help fund sight-saving research.
This year’s dinner will be celebrating the historic FDA approval of Spark Therapeutics’ vision-restoring gene therapy, known as LUXTURNA™. It is the first FDA-approved gene therapy for the eye, and has enabled children and adults who were virtually blind to put away their navigational canes, see the stars in the sky, and recognize the faces of their loved ones.
Co-founder and CEO of Spark Therapeutics Jeffrey D. Marrazzo and former Secretary of Health and Human Services Tommy G. Thompson will be presented with the Foundation’s Visionary Awards during the event.
“The Love of Sight dinner strengthens the Foundation’s commitment to raising vital funds for research,” said Benjamin Yerxa, PhD, FFB’s chief executive officer. “Research to find treatments and cures for retinal degenerative diseases has celebrated amazing discoveries in the last decade, but we need to keep funding researchers to continue the fight against blinding retinal diseases until all are eradicated.”
Event co-chairs are Ann and Tom Korologos and the honorary co-chairs are FFB’s co-founders Gordon & Lulie Gund. The emcee will be NBC News White House Correspondent Peter Alexander.
“It has been amazing to be a part of the Foundation’s continued success for the last 16 years,” said dinner co-chair Ann Korologos. “This powerful evening brings together all the science and government leaders behind sight-saving research for a chance to honor key visionaries throughout the country,” said dinner co-chair Tom Korologos.
The mission of the Foundation Fighting Blindness is to drive the research that will bring an end to the entire spectrum of retinal degenerative diseases including: retinitis pigmentosa, age-related macular degeneration, Stargardt disease, and Usher syndrome. The conditions affect more than 10 million people in the US and 150 million people worldwide. In addition to funding research at prominent academic labs, FFB is partnering with biotechs and pharmaceuticals to advance emerging therapies into and through clinical trials and out to the people who need them. Visit www.FightBlindness.org for the latest information on retinal disease research. Follow the Foundation on Facebook and Twitter.